Increased sugar intake as a form of compensatory hyperphagia in patients with type 2 diabetes under dapagliflozin treatment.

Ichiro Horie,Norio Abiru,Ryoko Hongo,Takeshi Nakamura,Ayako Ito,Ai Haraguchi,Shoko Natsuda,Ikuko Sagara,Takao Ando,Atsushi Kawakami

Diabetes Research and Clinical Practice（2018）

引用 47|浏览12

暂无评分

摘要

•Compensatory hyperphagia caused by SGLT2 inhibitors is known in animal models.•Compensatory hyperphagia was studied by a dietary questionnaire in human.•Our results suggest dapagliflozin treatment increased intake of sucrose.•The increased sugar intake may contribute to compensatory hyperphagia.

查看译文

关键词

SGLT2,SGLT2i,BDHQ,DHQ,GLP-1,eGFR,BMI,BUN,AST,ALT,γ-GTP,HDL,LDL,SD,0M,3M,P,F,C

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要